Persistent Expression of Recipient-type ABH Antigen after ABO-incompatible Allogeneic Hematopoietic Stem Cell Transplantation

Intern Med. 2022 Jun 15;61(12):1887-1890. doi: 10.2169/internalmedicine.8315-21. Epub 2021 Nov 20.

Abstract

In general, the recipient's ABO blood type changes to the donor's ABO blood type after ABO-incompatible allogeneic hematopoietic stem cell transplantation (HSCT). However, we experienced a 26-year-old male with acute myelogenous leukemia (AML) who underwent ABO-incompatible HSCT twice and persistently showed his original blood type even after demonstrating complete donor-type chimerism. Based on the results of various examinations, we considered that the antigen of the recipient's original blood type persistently synthesized in the recipient's non-hematopoietic organs was secreted and adsorbed on the surface of donor-derived RBCs. We should therefore perform detailed examinations to determine the precise blood type after ABO-incompatible HSCT.

Keywords: ABO blood group antigen; ABO-incompatibility; allogeneic HSCT; blood type; transfusion.

Publication types

  • Case Reports

MeSH terms

  • ABO Blood-Group System
  • Adult
  • Blood Group Incompatibility
  • Hematopoietic Stem Cell Transplantation* / methods
  • Humans
  • Leukemia, Myeloid, Acute* / therapy
  • Male
  • Tissue Donors

Substances

  • ABO Blood-Group System